Castillo Kirsten 4

What Happened
Kirsten Castillo, a director of Ocugen, Inc. (OCGN), was granted an award of derivative securities representing 170,100 shares on June 11, 2026. The filing shows an acquisition at $0.00 (no cash paid). This is a compensation/award transaction rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-11; Form 4 filed: 2026-06-15 (filed within the standard reporting window).
• Transaction type/code: A (Grant/Award of derivative securities). Price reported: $0.00.
• Shares/units granted: 170,100 (derivative securities tied to common stock).
• Shares owned after the transaction: not specified in the filing.
• Footnote: Vesting occurs upon the earlier of (a) June 11, 2027 or (b) Ocugen’s next annual meeting of stockholders, subject to Castillo’s continued service through the applicable vesting date.
• No immediate sale or exercise reported in this filing.

Context
This filing records a compensatory award that will convert into equity only if/when the award vests under the stated schedule. Such grants are common for directors and are not direct market purchases or sales; they signal compensation-related equity grants rather than a straightforward bullish or bearish trading decision.